Half-year report · HY
7730.TEDINET S100XYSX
Period2025-09-01 → 2026-02-28
Filed2026-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.1bn | 2025-09-01 → 2026-02-28 | Cons. | Net sales |
| Revenue | ¥30.0bn | 2024-09-01 → 2025-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.8bn | 2024-09-01 → 2025-02-28 | Cons. | Net sales |
| Operating income | ¥5.1bn | 2025-09-01 → 2026-02-28 | Cons. | Operating income |
| Operating income | ¥4.2bn | 2024-09-01 → 2025-02-28 | Cons. | Operating income |
| Ordinary income | ¥5.6bn | 2025-09-01 → 2026-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥8.3bn | 2024-09-01 → 2025-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.3bn | 2024-09-01 → 2025-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥5.6bn | 2025-09-01 → 2026-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥4.3bn | 2024-09-01 → 2025-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.9bn | 2025-09-01 → 2026-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.6bn | 2024-09-01 → 2025-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.9bn | 2024-09-01 → 2025-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.9bn | 2025-09-01 → 2026-02-28 | Cons. | Profit loss |
| Net income | ¥2.9bn | 2024-09-01 → 2025-02-28 | Cons. | Profit loss |
| Total assets | ¥61.5bn | at 2026-02-28 | Cons. | Assets |
| Total assets | ¥58.0bn | at 2025-08-31 | Cons. | Assets |
| Total assets | ¥58.3bn | at 2025-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.8bn | at 2026-02-28 | Cons. | Liabilities |
| Total liabilities | ¥4.4bn | at 2025-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥56.7bn | at 2026-02-28 | Cons. | Net assets |
| Net assets / equity | ¥53.6bn | at 2025-08-31 | Cons. | Net assets |
| Net assets / equity | ¥53.4bn | at 2025-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥22.8bn | at 2026-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.4bn | at 2025-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥21.9bn | at 2026-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥17.4bn | at 2025-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥17.5bn | at 2025-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.0bn | at 2024-08-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥6.3bn | 2025-09-01 → 2026-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.0bn | 2024-09-01 → 2025-08-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.0bn | 2024-09-01 → 2025-02-28 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥541m | 2025-09-01 → 2026-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.2bn | 2024-09-01 → 2025-08-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.6bn | 2024-09-01 → 2025-02-28 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.3bn | 2025-09-01 → 2026-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.9bn | 2024-09-01 → 2025-08-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.3bn | 2024-09-01 → 2025-02-28 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥39.58 | 2025-09-01 → 2026-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.14 | 2024-09-01 → 2025-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.85 | 2024-09-01 → 2025-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 92.2% | at 2026-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.4% | at 2025-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.6% | at 2025-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-09-01 → 2026-02-28 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-09-01 → 2026-02-28 | ¥0 |
| Dentalreportable segment | revenue | 2025-09-01 → 2026-02-28 | ¥5.3bn |
| Dentalreportable segment | revenue external | 2025-09-01 → 2026-02-28 | ¥5.3bn |
| Dentalreportable segment | segment profit | 2025-09-01 → 2026-02-28 | ¥1.0bn |
| Eyeless Needlereportable segment | revenue | 2025-09-01 → 2026-02-28 | ¥5.9bn |
| Eyeless Needlereportable segment | revenue external | 2025-09-01 → 2026-02-28 | ¥5.9bn |
| Eyeless Needlereportable segment | revenue intersegment | 2025-09-01 → 2026-02-28 | ¥0 |
| Eyeless Needlereportable segment | segment profit | 2025-09-01 → 2026-02-28 | ¥2.4bn |
| Surgicalreportable segment | revenue | 2025-09-01 → 2026-02-28 | ¥4.9bn |
| Surgicalreportable segment | revenue external | 2025-09-01 → 2026-02-28 | ¥4.9bn |
| Surgicalreportable segment | segment profit | 2025-09-01 → 2026-02-28 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-09-01 → 2026-02-28 | ¥16.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-09-01 → 2026-02-28 | ¥16.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-09-01 → 2026-02-28 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-09-01 → 2026-02-28 | ¥5.1bn |
| Reconciling Itemsreconciling | revenue | 2024-09-01 → 2025-02-28 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥0 |
| Dentalreportable segment | revenue | 2024-09-01 → 2025-02-28 | ¥4.5bn |
| Dentalreportable segment | revenue external | 2024-09-01 → 2025-02-28 | ¥4.5bn |
| Dentalreportable segment | segment profit | 2024-09-01 → 2025-02-28 | ¥460m |
| Eyeless Needlereportable segment | revenue | 2024-09-01 → 2025-02-28 | ¥5.6bn |
| Eyeless Needlereportable segment | revenue external | 2024-09-01 → 2025-02-28 | ¥5.6bn |
| Eyeless Needlereportable segment | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥0 |
| Eyeless Needlereportable segment | segment profit | 2024-09-01 → 2025-02-28 | ¥2.1bn |
| Surgicalreportable segment | revenue | 2024-09-01 → 2025-02-28 | ¥4.7bn |
| Surgicalreportable segment | revenue external | 2024-09-01 → 2025-02-28 | ¥4.7bn |
| Surgicalreportable segment | segment profit | 2024-09-01 → 2025-02-28 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-09-01 → 2025-02-28 | ¥14.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-09-01 → 2025-02-28 | ¥14.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-09-01 → 2025-02-28 | ¥4.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 515
| Item | Context | Value | Unit |
|---|---|---|---|
| Salaries and allowances sga | Prior1InterimDuration | 1431000000 | JPY |
| Salaries and allowances sga | InterimDuration | 1513000000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 154000000 | JPY |
| Provision for bonuses sga | InterimDuration | 250000000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 35000000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 40000000 | JPY |
| Research and development expenses sga | Prior1InterimDuration | 1311000000 | JPY |
| Research and development expenses sga | InterimDuration | 1212000000 | JPY |
| Depreciation sga | Prior1InterimDuration | 192000000 | JPY |
| Depreciation sga | InterimDuration | 175000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02340-000SurgicalReportableSegmentsMember | 4718000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02340-000EyelessNeedleReportableSegmentsMember | 5556000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02340-000DentalReportableSegmentsMember | 4535000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 14810000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 14810000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02340-000SurgicalReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02340-000EyelessNeedleReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02340-000DentalReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 0 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | -0 | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02340-000SurgicalReportableSegmentsMember | 4718000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02340-000EyelessNeedleReportableSegmentsMember | 5557000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02340-000DentalReportableSegmentsMember | 4535000000 | JPY |
| Net sales | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 14811000000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | -0 | JPY |
| Net sales | Prior1InterimDuration | 14810000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02340-000SurgicalReportableSegmentsMember | 1643000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02340-000EyelessNeedleReportableSegmentsMember | 2068000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02340-000DentalReportableSegmentsMember | 460000000 | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 4172000000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1InterimDuration | 4172000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02340-000SurgicalReportableSegmentsMember | 4880000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02340-000EyelessNeedleReportableSegmentsMember | 5882000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02340-000DentalReportableSegmentsMember | 5343000000 | JPY |
| Revenues from external customers | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 16106000000 | JPY |
| Revenues from external customers | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | InterimDuration | 16106000000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E02340-000SurgicalReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E02340-000EyelessNeedleReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E02340-000DentalReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 0 | JPY |
| Transactions with other segments | InterimDuration_ReconcilingItemsMember | -0 | JPY |
| Transactions with other segments | InterimDuration | － | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E02340-000SurgicalReportableSegmentsMember | 4880000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E02340-000EyelessNeedleReportableSegmentsMember | 5883000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E02340-000DentalReportableSegmentsMember | 5343000000 | JPY |
| Net sales | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 16107000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |